Cardio Diagnostics Holdings, Inc. (CDIO)
1.925
-0.10
(-5.17%)
USD |
NASDAQ |
Aug 24, 16:00
1.97
+0.04
(+2.34%)
After-Hours: 20:00
Cardio Diagnostics Holdings Debt to Equity Ratio : 0.0498 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0498 |
| March 31, 2026 | 0.0599 |
| December 31, 2025 | 0.0998 |
| September 30, 2025 | 0.0597 |
| June 30, 2025 | 0.0641 |
| March 31, 2025 | 0.07 |
| December 31, 2024 | 0.1015 |
| September 30, 2024 | 0.1955 |
| June 30, 2024 | 0.2831 |
| March 31, 2024 | 0.351 |
| December 31, 2023 | 0.4263 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.8155 |
| June 30, 2023 | 0.412 |
| March 31, 2023 | 0.2575 |
| December 31, 2022 | 0.1974 |
| September 30, 2022 | 0.0066 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 1.852 |
| June 30, 2021 | 1.829 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Exicure, Inc. | 0.00 |
| Century Therapeutics, Inc. | 0.1664 |
| Absci Corp. | 0.0156 |
| Celularity, Inc. | -1.963 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.926M |
| Total Liabilities (Quarterly) | 0.4998M |
| Shareholders Equity (Quarterly) | 7.426M |
| Current Ratio | 17.15 |
| Net Debt Paydown Yield | 1.32% |